Table 4 Enrich pathways in blue module
From: Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
Blue Module | |||||
|---|---|---|---|---|---|
Description | Genes in Gene Set (K) | Genes in Overlap (k) | k/K ratio | p-value | FDR q-value |
Cell adhesion molecules(CAMs) | 134 | 9 | 0.0672 | 1.06E-08 | 1.97E-06 |
Regulation of actin cytoskeleton | 216 | 10 | 0.0463 | 5.56E-08 | 5.17E-06 |
Chemokine signaling pathway | 190 | 9 | 0.0474 | 2.14E-07 | 1.33E-05 |
Cytokine-cytokine receptor interaction | 267 | 10 | 0.0375 | 3.97E-07 | 1.82E-05 |
Primary immunodeficiency | 35 | 5 | 0.1429 | 4.90E-07 | 1.82E-05 |
Leukocyte transendothelial migration | 118 | 7 | 0.0593 | 1.10E-06 | 3.41E-05 |
Natural killer cell mediated cytotoxicity | 137 | 7 | 0.0511 | 2.99E-06 | 7.94E-05 |
Complement and coagulation cascades | 69 | 5 | 0.0725 | 1.50E-05 | 3.49E-04 |
Hematopoietic cell lineage | 88 | 5 | 0.0568 | 4.88E-05 | 1.01E-03 |
Jak-STAT signaling pathway | 155 | 6 | 0.0387 | 7.36E-05 | 1.37E-03 |
Toll-like receptor signaling pathway | 102 | 5 | 0.049 | 9.86E-05 | 1.67E-03 |